Pfizer Elranatamab gets USFDA Breakthrough Therapy Designation for Relapsed or Refractory Multiple Myeloma Ruchika Sharma4 Nov 2022 3:00 PM ISTNew York: Pfizer Inc. has announced that its investigational cancer immunotherapy, elranatamab, has received Breakthrough Therapy Designation from the...
Thermo Fisher Scientific to acquire The Binding Site Group for USD 2.6 billion Ruchika Sharma1 Nov 2022 11:19 AM ISTWaltham: Thermo Fisher Scientific Inc. has announced that it has entered into a definitive agreement to acquire The Binding Site Group ("The Binding...
Janssen TECVAYLI gets USFDA nod for relapsed or refractory multiple myeloma Ruchika Sharma29 Oct 2022 10:00 AM ISTTECVAYLI is a first-in-class, bispecific T-cell engager antibody that is administered as a subcutaneous treatment.
Dr Reddy's Labs unveils cancer drug Lenalidomide in US Ruchika Sharma8 Sept 2022 2:47 PM ISTDr. Reddy's Lenalidomide Capsules are available in strengths of 2.5 mg, 5 mg, and 10 mg, each in a bottle-count size of 28, as well as 15 mg, 20 mg,...
Cipla Cancer drug Lenalidomide bags USFDA okay Ruchika Sharma7 Sept 2022 4:22 PM ISTMumbai: Drugmaker, Cipla Limited, today announced that the company has received final approval for its Abbreviated New Drug Application (ANDA) for...
Janssen Pharma gets USFDA Breakthrough Therapy Designation for Multiple Myeloma treatment Talquetamab Ruchika Sharma30 Jun 2022 3:02 PM ISTTalquetamab is an investigational, off-the-shelf, T-cell redirecting bispecific antibody targeting both GPRC5D, a novel drug target, on multiple...
Three-drug therapy with autologous stem cell transplant improves survival in multiple myeloma: NEJM Dr. Kamal Kant Kohli15 Jun 2022 8:00 PM ISTResearchers have found in a new study appearing in New England journal of Medicine that among adults with multiple myeloma, RVD plus ASCT was...
Gland Pharma launches cancer drug Bortezomib in US Ruchika Sharma5 May 2022 12:06 PM ISTHyderabad: Gland Pharma Limited, a generic injectable focused pharmaceutical company, through its partner has launched Bortezomib for Injection, 3.5 ...
Aurobindo Pharma arm bags USFDA nod for cancer drug Bortezomib Ruchika Sharma4 May 2022 11:00 AM ISTHyderabad: Drugmaker, Aurobindo Pharma Limited, has recently announced that its wholly owned subsidiary company, Eugia Pharma Specialties...
Zydus Lifesciences bags USFDA nod for Bortezomib for Injection to treat cancer Ruchika Sharma3 May 2022 3:26 PM ISTThe drug will be manufactured at Zydus Hospira.
Patients with kidney disease may have an increased risk of cancer Dr. Kamal Kant Kohli14 April 2022 9:00 AM ISTPatients with kidney disease may have an increased risk of cancer and may be more likely to die from cancer. Researchers used healthcare databases in...
GSK gets CDSCO panel okay to conduct study on antineoplastic drug Belantamab Mafadotin Dr. Divya Colin18 March 2022 2:05 PM ISTNew Delhi: In a significant development, GSK Pharmaceuticals ( India) has got approval from the Subject Expert Committee (SEC) of the Central Drug...
